Competitive intelligence on 
 small-molecule drugs and 
 the 90,000 global patents 
 covering them 

Start your free trial now

DrugPatentWatch Ultimate Plan Preview

Profile for Tradename: QVAR 40

« Back to Dashboard

Qvar 40 is a drug marketed by Teva Branded Pharm and is included in one NDA. It is available from three suppliers. There are four patents protecting this drug.

The generic ingredient in QVAR 40 is beclomethasone dipropionate. There are nineteen drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the beclomethasone dipropionate profile page.

Summary for Tradename: QVAR 40

Suppliers: see list3

Pharmacology for Tradename: QVAR 40

Clinical Trials for: QVAR 40

Asthma Clinical Research Network (ACRN) Trial - Best Adjustment Strategy for Asthma in Long Term (BASALT)
Status: Completed Condition: Asthma

Childhood Asthma Research and Education (CARE) Network Trial - Treating Children to Prevent Exacerbations of Asthma (TREXA)
Status: Completed Condition: Asthma

Examining the Link Between Obesity, Inflammation, and Response to Asthma Medications
Status: Completed Condition: Asthma; Obesity

Sunovion Growth Study Pediatric Subjects With Mild Asthma & Allergic Rhinitis
Status: Recruiting Condition: Asthma; Allergic Rhinitis

Additive Effects of QVAR to (Seretide) on Surrogate Markers of Airway Inflammation in Refractory Asthma
Status: Completed Condition: Asthma

Study to Assess the Efficacy and Safety of BDP HFA Nasal Aerosol in Patients 12 Years and Older With SAR
Status: Completed Condition: Seasonal Allergic Rhinitis; Hayfever

Pharmacokinetic Clinical Study of CHF1535 NEXT DPI® Versus CHF1535 pMDI
Status: Completed Condition: Asthma

A Study to Investigate the Pharmacokinetics and Safety of Beclomethasone Dipropionate Administered by Breath-Actuated Inhaler and Metered-Dose Inhaler in Healthy Adults
Status: Completed Condition: Pharmacokinetics

Hypothalamic-Pituitary-Adrenal (HPA)-Axis Study in Pediatric Subjects With Perennial Allergic Rhinitis (PAR)
Status: Completed Condition: Allergic Rhinitis

Effect of Fostair® on Biomarkers of Platelet Adhesion in Idiopathic Pulmonary Fibrosis
Status: Not yet recruiting Condition: Idiopathic Pulmonary Fibrosis

Courtesy of
See more clinical trials for this drug
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva Branded Pharm
beclomethasone dipropionate
AEROSOL, METERED;INHALATION020911Sep 15, 2000RXYes5,776,432<disabled>Y<disabled>
Teva Branded Pharm
beclomethasone dipropionate
AEROSOL, METERED;INHALATION020911Sep 15, 2000RXYes5,683,677<disabled>Y<disabled>
Teva Branded Pharm
beclomethasone dipropionate
AEROSOL, METERED;INHALATION020911Sep 15, 2000RXYes6,446,627<disabled>Y<disabled>
Teva Branded Pharm
beclomethasone dipropionate
AEROSOL, METERED;INHALATION020911Sep 15, 2000RXYes5,605,674<disabled><disabled>
This preview shows a limited data set
Subscribe for full access, or try a free trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

DrugPatentWatch Archives

You are viewing the current data set
Select a link below to view the archives:

 2000   2001   2002   2003   2004   2005   2006   2007   2008   2009   2010   2011   2012   2013   2014  

For more information try a free trial or see the plan comparison

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2015 thinkBiotech LLC
ISSN: 2162-2639

Preferred citation:
Friedman, Y. Location of pharmaceutical innovation: 2000–2009 Nature Reviews Drug Discovery 9, 835–836 (2010).

Connect with Social Media:

Follow DrugPatentWatch on Twitter
Connect with DrugPatentWatch on Linkedin
Drug Patents on LinkedIn